IFITM3 and susceptibility to respiratory viral infections in the community

Journal of Infectious Diseases

Volumn 209, Issue 7, 2014, Pages 1028-1031

  Mills, Tara C ^a   Rautanen, Anna ^a   Elliott, Katherine S ^a   Parks, Tom ^a   Naranbhai, Vivek ^a   Ieven, Margareta M ^f   Butler, Christopher C ^c   Little, Paul ^d   Verheij, Theo ^h   Garrard, Chris S ^b   Hinds, Charles ^e   Goossens, Herman ^g   Chapman, Stephen ^a   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

association study; genetics; H1N1; IFITM3; infectious disease; Influenza; LRTI; Virus

Indexed keywords

ARTICLE; CAUCASIAN; COMMUNICABLE DISEASE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INFECTION SENSITIVITY; INFLUENZA A (H1N1); INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN 3 GENE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL RESPIRATORY TRACT INFECTION;

ASSOCIATION STUDY; GENETICS; H1N1; IFITM3; INFECTIOUS DISEASE; INFLUENZA; LRTI; VIRUS;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RESPIRATORY TRACT INFECTIONS; RNA-BINDING PROTEINS; VIRUS DISEASES;

EID: 84898939122     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit468     Document Type: Article

References (15)

1. Brass AL, Huang IC, Benita Y, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139:1243-54
2. Li K, Markosyan RM, Zheng Y-M, et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 2013; 9:e1003124
3. Everitt AR, Clare S, Pertel T, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484:519-23
4. The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491:56-65
5. Hindorff LA, MacArthur J, Morales J, et al. A catalog of published genome-wide association studies. www.genome.gov/gwastudies. Accessed 25 January 2012
6. Marchini J, Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 2010; 11:499-511
7. Zhang Y-H, Zhao Y, Li N, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nature Comms 2013; 4:1418
8. Hinds CJ, Garrard CS. UK Critical Care Genomics (UKCCG) group. http://www.ukccg-gains.org/index.htm. Accessed 2 December 2012
9. Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratorytract infection in primary care when pneumonia is not suspected: A-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013; 13:123-9
10. Loens K, van Loon AM, Coenjaerts F, et al. Performance of different mono-And multiplex nucleic acid amplification tests on a multipathogen external quality assessment panel. J Clin Microbiol 2012; 50: 977-87
11. Purcell S. PLINK v1.07. Whole genome association analysis toolset. http://pngu.mgh.harvard.edu/purcell/plink/. Accessed 20 January 2013
12. Purcell S, Neale B, Todd-Brown K, et al. PLINK: A tool set for wholegenome association and population-based linkage analyses. Am J Hum Genet 2007; 81:559-75. (Pubitemid 47330214
13. Jiang D, Weidner JM, Qing M, et al. Identification of five interferoninduced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol 2010; 84:8332-41
14. Huang IC, Bailey CC, Weyer JL, et al. Distinct patterns of IFITMmediated restriction of filoviruses, SARS coronavirus, and influenza Avirus. PLoS Pathog 2011; 7:e1001258
15. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011; 472:481-5